Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection
NCT02654158 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2400
Last updated 2017-05-22
Summary
Phase IV trial,Single-arm, multi-centre clinical trial to assess the efficacy and safety of Fuganlin Oral Liquid in children with acute upper respiratory infection
Conditions
- Acute Upper Respiratory Infection
Interventions
- DRUG
-
Low-dose of Fuganlin Oral Liquid
less than 1 years old: 5mL each time and three times a day 1\~3 years old: 10mL each time and three times a day 4\~6 years old: 10mL each time and four times a day 7\~12 years old: 10mL each time and five times a day
- DRUG
-
High-dose of Fuganlin Oral Liquid
less than 1 years old: 10mL each time and three times a day 1\~3 years old: 20mL each time and three times a day 4\~6 years old: 20mL each time and four times a day 7\~12 years old: 20mL each time and five times a day
Sponsors & Collaborators
-
Guangzhou Yipinhong Pharmaceutical CO.,LTD
lead INDUSTRY
Principal Investigators
-
Li xinmin, PhD · The First Affiliated Hospital of Tianjing University of Traditional Chinese Medicine
-
Chang ke, MD · Chengdu University of Traditional Chinese Medicine
-
Meng qingping, MD · Zhengzhou Children's Hospital
-
Tao lei, MD · Huanggang Maternal and Child Health Hospital
-
Ding ying, MD · Children's Hospital of The First Affiliated Hospital of Henan College of Traditional Chinese Medicine
-
Xiang xixiong, PhD · Hubei Hospital of Traditional Chinese Medicine
-
Cheng ji, MD · Second Affiliated Hospital of Wenzhou Medical University
-
Ying yong, MD · Affiliated Shanghai Children's Medical Center of Shanghai Jiaotong University School of medicine
-
Liu changshan, MD · Tianjin Medical University Second Hospital
-
Mou qinghui, MD · Jinan children's hospital
-
Liu yulin, MD · BoAi Hospital of Zhongshan
-
Wang lisheng, PhD · Shenzhen Children's Hospital
-
Zhao deyu, PhD · Affiliated Nanjing Children's Hospital of Nanjing Medical University
-
Du yonggang, MD · Changzhi People's Hospital
-
Su baoling, MD · Affiliated Heji Hospital of Changzhi Medical College
-
Qing yanhong, MD · Affiliated Hospital of Shanxi College of Traditional Chinese medicine
-
Cheng zhimin, PhD · Affiliated Children's Hospital of Zhejiang University School of Medicine
-
Lin yan, MD · Chengdu Women and Children's Hospital
-
Xu youjia, MD · Guangdong Provincial Hospital of Traditional Chinese Medicine
-
Zhang mingying, MD · Beijing Shunyi Hospital of China Medical University
Eligibility
- Min Age
- 1 Year
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2017-05-31
- Completion
- 2017-05-31
Countries
- China
Study Locations
More Related Trials
-
Yinhu Qingwen Granule in the Treatment of Viral Pneumonia
NCT04955223 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza
NCT01063933 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study to Learn About The Study Medicine (Called PF-06823859) in Healthy Chinese Participants
NCT05257798 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Influenza and ARVI in Children by Kagocel ®
NCT04651491 ·Status: COMPLETED
-
Antiviral Therapy for Influenza A H1N1
NCT00985582 ·Status: COMPLETED
-
Safety and Efficacy of ADC189 in Children 2-11 Years Old With Influenza
NCT06507813 ·Status: COMPLETED ·Phase: PHASE3
-
Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts
NCT05415241 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections
NCT03162458 ·Status: COMPLETED ·Phase: PHASE3
-
Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults
NCT00793000 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
NCT01224795 ·Status: TERMINATED ·Phase: PHASE3
-
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Onradivir Tablets in Participants Aged 12 to 17 Years With Uncomplicated Influenza A.
NCT07229547 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension
NCT06643156 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Dose Study of Peramivir for Influenza Treatment
NCT00297050 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age
NCT01037634 ·Status: WITHDRAWN ·Phase: PHASE2
-
Test-and-treat for Influenza in Homeless Shelters
NCT04141917 ·Status: TERMINATED ·Phase: PHASE4
-
Study on Safety and Effectiveness of Ergoferon in the Treatment of Flu / ARVI in Outpatients.
NCT04413929 ·Status: COMPLETED
-
The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients
NCT04475107 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A
NCT07229820 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness
NCT04610047 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A
NCT07229807 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of Avonex to Determine the Effects of Dose Titration on the Incidence of Flu Like Symptoms in Healthy Volunteers
NCT01119677 ·Status: COMPLETED ·Phase: PHASE1
-
The Chloroquine for Influenza Prevention Trial
NCT01078779 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza Symptoms
NCT06774859 ·Status: COMPLETED ·Phase: PHASE3
-
Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza
NCT00391768 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.
NCT03679143 ·Status: COMPLETED ·Phase: PHASE1